<DOC>
	<DOCNO>NCT00383266</DOCNO>
	<brief_summary>This study investigational agent , pemetrexed , combination standard chemotherapy drug , carboplatin , treatment patient metastatic esophageal cancer .</brief_summary>
	<brief_title>A Phase II Study Pemetrexed Carboplatin Treatment Esophageal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Patients must histologically cytologically proven metastatic recurrent esophageal cancer . Both adenocarcinoma squamous carcinoma eligible study . Patients small cell carcinoma sarcoma esophagus eligible study . Patients may prior chemotherapy treatment metastatic esophageal cancer . Patients may chemotherapy 5FU combined definitive radiotherapy curative intent adjuvant , neoadjuvant , definite set locally advanced esophageal cancer , less one year prior trial enrollment . Patients may receive pemetrexed past . Patients radiotherapy esophageal cancer must complete radiotherapy least four week prior entry study . Patients need measurable disease . Lesions consider measurable include follow : Bone lesion Brain metastasis leptomeningeal disease Ascites Pleural/pericardial effusion Abdominal mass confirm followed imaging technique Cystic lesion Tumor lesion situate previously irradiate area ECOG ) performance status 02 . Life expectancy &gt; =12 week . Patients must adequate bone marrow function define : white blood cell ( WBC ) &gt; = 3000/mm^3 , absolute neutrophil count ( ANC ) &gt; = 1,500/mm^3 , hemoglobin &gt; = 9.0 g/dL , platelet count &gt; = 100,000/mm^3 . Patients must adequate liver function define : Bilirubin &lt; = 1.5 x institutional normal ALT/AST &lt; 3 x institutional normal . Patients must adequate renal function define : serum creatinine &lt; = 3.0 mg/dL creatinine clearance &gt; = 45 mL/min . Radiation therapy brain metastasis complete least four week prior enrollment protocol . Patients must recover uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , uncontrolled symptomatic cardiac arrhythmia . Patients must able compliant premedications dexamethasone , folic acid , vitamin B12 . For sexually active woman childbearing age , use adequate contraception ( hormonal barrier method birth control ) require prior study entry duration study participation . Age &gt; = 18 year . Written consent . Ibuprofen ( 400 mg qid ) administer Alimta patient normal renal function ( creatinine clearance &gt; 80 mL/min Patients thirdspace fluid ( pleural effusion , ascites , etc . ) uncontrolled drainage . Pregnant nursing female Patients preexist neuropathy great equal grade 2 . Patients know active CNS metastasis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>